View in EDS

Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation.

Saved in:
Bibliographic Details
Title: Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation.
Authors: Wong HH; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK., Parkinson C; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK., Ledermann JA; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, University College London, 90 Tottenham Court Road, London W1T 4TJ, UK., Brenton JD; Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK., Merger M; Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riss, Germany., Shaw A; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK., Patterson A; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK., Shafi M; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK., Earl HM; Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Hills Road, Cambridge CB2 0QQ, UK.
Source: Gynecologic oncology case reports [Gynecol Oncol Case Rep] 2012 Oct 17; Vol. 3, pp. 7-10. Date of Electronic Publication: 2012 Oct 17 (Print Publication: 2012).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101599306 Publication Model: eCollection Cited Medium: Print ISSN: 2211-338X (Print) Linking ISSN: 2211338X NLM ISO Abbreviation: Gynecol Oncol Case Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2211-338X
DOI:10.1016/j.gynor.2012.10.003